Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

56 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Managing neutropenia by pegfilgrastim in patients affected by relapsed/refractory multiple myeloma treated with bendamustine-bortezomib-dexamethasone.
Cerchione C, Catalano L, Peluso I, Nappi D, Di Perna M, Salvatore D, Migliaccio I, Picardi M, Pane F. Cerchione C, et al. Among authors: migliaccio i. Support Care Cancer. 2016 Dec;24(12):4835-4837. doi: 10.1007/s00520-016-3430-9. Epub 2016 Oct 10. Support Care Cancer. 2016. PMID: 27726031 Free PMC article. No abstract available.
Gilteritinib as treatment for extra-medullary relapse of FLT3-ITD acute myeloid leukemia FLT3-ITD, after allogeneic haematopoietic stem cell transplantation.
Iannotta R, Celentano M, Marotta S, Pedata CM, Riccardi C, Migliaccio I, Viola A, Muggianu SM, Falco C, Bovenzi D, Ferrara F, Picardi A. Iannotta R, et al. Among authors: migliaccio i. Leuk Res Rep. 2022 Jul 27;18:100340. doi: 10.1016/j.lrr.2022.100340. eCollection 2022. Leuk Res Rep. 2022. PMID: 35958243 Free PMC article.
Mutational Analysis of Circulating Tumor DNA in Patients With Estrogen Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer Receiving Palbociclib: Results From the TREnd Trial.
Migliaccio I, Romagnoli D, Galardi F, De Luca F, Biagioni C, Curigliano G, Criscitiello C, Minisini AM, Moretti E, Risi E, Guarducci C, Nardone A, Biganzoli L, Benelli M, Malorni L. Migliaccio I, et al. JCO Precis Oncol. 2024 Feb;8:e2300285. doi: 10.1200/PO.23.00285. JCO Precis Oncol. 2024. PMID: 38427931 Clinical Trial.
Serum thymidine kinase activity in patients with hormone receptor-positive and HER2-negative metastatic breast cancer treated with palbociclib and fulvestrant.
Malorni L, Tyekucheva S, Hilbers FS, Ignatiadis M, Neven P, Colleoni M, Henry S, Ballestrero A, Bonetti A, Jerusalem G, Papadimitriou K, Bernardo A, Seles E, Duhoux FP, MacPherson IR, Thomson A, Davies DM, Bergqvist M, Migliaccio I, Gebhart G, Zoppoli G, Bliss JM, Benelli M, McCartney A, Kammler R, De Swert H, Ruepp B, Fumagalli D, Maibach R, Cameron D, Loi S, Piccart M, Regan MM; International Breast Cancer Study Group; Breast International Group and PYTHIA Collaborators. Malorni L, et al. Among authors: migliaccio i. Eur J Cancer. 2022 Mar;164:39-51. doi: 10.1016/j.ejca.2021.12.030. Epub 2022 Feb 13. Eur J Cancer. 2022. PMID: 35172272 Clinical Trial.
Charting differentially methylated regions in cancer with Rocker-meth.
Benelli M, Franceschini GM, Magi A, Romagnoli D, Biagioni C, Migliaccio I, Malorni L, Demichelis F. Benelli M, et al. Among authors: migliaccio i. Commun Biol. 2021 Nov 2;4(1):1249. doi: 10.1038/s42003-021-02761-3. Commun Biol. 2021. PMID: 34728774 Free PMC article.
Correction: Activation of the IFN Signaling Pathway is Associated with Resistance to CDK4/6 Inhibitors and Immune Checkpoint Activation in ER-Positive Breast Cancer.
De Angelis C, Fu X, Cataldo ML, Nardone A, Pereira R, Veeraraghavan J, Nanda S, Qin L, Sethunath V, Wang T, Hilsenbeck SG, Benelli M, Migliaccio I, Guarducci C, Malorni L, Litchfield LM, Liu J, Donaldson J, Selenica P, Brown DN, Weigelt B, Reis-Filho JS, Park BH, Hurvitz SA, Slamon DJ, Rimawi MF, Jansen VM, Jeselsohn R, Osborne CK, Schiff R. De Angelis C, et al. Among authors: migliaccio i. Clin Cancer Res. 2021 Sep 1;27(17):4939. doi: 10.1158/1078-0432.CCR-21-2431. Clin Cancer Res. 2021. PMID: 34470810 No abstract available.
56 results